Patents Assigned to Philippe Yves-Remy Simon
  • Proteasome inhibiting ?-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders
    Patent number: 11053249
    Abstract: The present invention relates generally to proteasome inhibiting ?-lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: July 6, 2021
    Assignees: Philippe Yves-Remy Simon, VITA API
    Inventors: Philippe Yves-Rémy Simon, Henri Oreal, Gérard Audran, Marvin Schulz, Jean-Patrick Joly, Didier Siri, Anouk Siri